Visiting Professor Lecture Refractive Surgery - William F. Wiley, MD [NON-CME]

Click here to register for the livestream!

In this series, we welcome influential ophthalmologists from around the country and the world to speak at Wills Eye Hospital for the benefit of residents and practicing ophthalmologists. Presentations and lectures include clinical and non-clinical content, and reflections on each guest's professional journey. 

Medical Director of Cleveland Eye Clinic and Clear Choice LASIK Center divisions of Midwest Vision Partners (MVP.) He is an active board member of Midwest Vision Partners. Dr. Wiley has helped innovate numerous new technologies within the eye care space. He assisted in the pioneering of Intra-operative aberrometer through the early clinical trials from the original device to the current commercialized product. He helped develop the Less-drops formulation and MKO melt sedation products from Imprimis Pharmaceuticals.  Active investigator in numerous protocols, including the light adjustable IOL, trifocal IOLs, corneal inlays, toric IOLs, therapeutic dry eye treatments, excimer laser technology, and extended-release drug therapy.  Current President of OOSS (Outpatient Ophthalmic Surgery Society), Founding member of Vanguard Ophthalmology Society, past president of Society for Excellence in Eye care, past president and current Chair of AECOS, member of CEDARS/ASPENS Program Chair of Caribbean Eye Meeting, associate editor of Cataract and Refractive Surgery Today, Founder ad Director EyePrentice. 

This series is not certified for CME credit. 

Mitigation of Relevant Financial Relationships

In compliance with the Standards for Integrity and Independence in Accredited Continuing Education set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based upon clinical and scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that all individuals in a position to control the content of a CME activity (including faculty, planners, reviewers or others) have disclosed about all financial relationships they have with ineligible companies. All relevant financial relationships have been mitigated.

Ineligible companies are companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. The CME activity staff at Wills Eye Hospital report no financial relationships with ineligible companies.